Fialuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H10FIN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53T7IN77LC, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fialuridine, which bears US NIH Compound Identifier 50313. European Medicines Agency schedules Fialuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07622MIG. The term FIALURIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). FIALURIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fialuridine under HS 29349990 and SITC 51579. As of Q4 2014, FIALURIDINE remains the US FDA Preferred Term for this commodity. Fialuridine bears US NLM identifiers UMLS ID C0208078 and NCI Concept Code C73197. SMILES: IC1CN(C2OC(C(O)C2F)CO)C(=O)[NH]C1=O.